Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats

被引:82
|
作者
Jose Zarzuelo, Maria [1 ]
Jimenez, Rosario [1 ,3 ]
Galindo, Pilar [1 ]
Sanchez, Manuel [1 ]
Nieto, Ana [4 ]
Romero, Miguel [1 ]
Maria Quintela, Ana [1 ]
Lopez-Sepulveda, Rocio [1 ]
Gomez-Guzman, Manuel [1 ]
Bailon, Elvira [1 ]
Rodriguez-Gomez, Isabel [2 ]
Zarzuelo, Antonio [1 ,5 ]
Galvez, Julio [1 ,5 ]
Tamargo, Juan [6 ]
Perez-Vizcaino, Francisco [6 ,7 ,8 ]
Duarte, Juan [1 ]
机构
[1] Univ Granada, Sch Pharm, Dept Pharmacol, E-18071 Granada, Spain
[2] Univ Granada, Sch Med, Dept Physiol, E-18071 Granada, Spain
[3] Ctr Biomed Res, Granada, Spain
[4] Anapath, Anat Pathol Lab, Granada, Spain
[5] Ciber Enfermedades Hepat & Digest, Madrid, Spain
[6] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[7] Ciber Enfermedades Resp, Madrid, Spain
[8] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
关键词
PPAR beta/delta; spontaneously hypertensive rat; endothelial dysfunction; NADPH oxidase; regulators of G protein-coupled signaling proteins; PROTEIN-KINASE-C; ANGIOTENSIN-II; OXIDATIVE STRESS; FATTY-ACID; PPAR-ALPHA; KAPPA-B; EXPRESSION; ENDOTHELIN-1; HEART; HYPERTROPHY;
D O I
10.1161/HYPERTENSIONAHA.111.174490
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta) has been shown to improve insulin resistance and plasma high-density lipoprotein levels, but nothing is known about its effects in genetic hypertension. We studied whether the PPAR beta agonist GW0742 might exert antihypertensive effects in spontaneously hypertensive rats (SHRs). The rats were divided into 4 groups, Wistar Kyoto rat-control, Wistar Kyoto rat-treated (GW0742, 5 mg . kg(-1) . day(-1) by oral gavage), SHR-control, and SHR-treated, and followed for 5 weeks. GW0742 induced a progressive reduction in systolic arterial blood pressure and heart rate in SHRs and reduced the mesenteric arterial remodeling, the increased aortic vasoconstriction to angiotensin II, and the endothelial dysfunction characteristic of SHRs. These effects were accompanied by a significant increase in endothelial NO synthase activity attributed to upregulated endothelial NO synthase and downregulated caveolin 1 protein expression. Moreover, GW0742 inhibited vascular superoxide production, downregulated p22(phox) and p47(phox) proteins, decreased both basal and angiotensin II-stimulated NADPH oxidase activity, inhibited extracellular-regulated kinase 1/2 activation, and reduced the expression of the proinflammatory and proatherogenic genes, interleukin 1 beta, interleukin 6, or intercellular adhesion molecule 1. None of these effects were observed in Wistar Kyoto rats. PPAR beta activation, both in vitro and in vivo, increased the expression of the regulators of G protein-coupled signaling proteins RGS4 and RGS5, which negatively modulated the vascular actions of angiotensin II. PPAR beta activation exerted antihypertensive effects, restored the vascular structure and function, and reduced the oxidative, proinflammatory, and proatherogenic status of SHRs. We propose PPAR beta as a new therapeutic target in hypertension. (Hypertension. 2011;58:733-743.)
引用
收藏
页码:733 / U437
页数:23
相关论文
共 50 条
  • [21] Cardioprotective effects of thiazolidinediones, peroxisome proliferator-activated receptor-γ agonists
    Yue, TL
    DRUGS OF TODAY, 2003, 39 (12) : 949 - 960
  • [22] Peroxisome proliferator-activated receptor-γ and esophageal cancer
    Shimada, T
    Terano, A
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (01): : 4 - 5
  • [23] Peroxisome proliferator-activated receptor-γ in the renal mesangium
    Hsueh, WA
    Nicholas, SB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02): : 191 - 195
  • [24] Peroxisome proliferator-activated receptor-? cofactors in neurodegeneration
    Katsouri, Loukia
    Blondrath, Katrin
    Sastre, Magdalena
    IUBMB LIFE, 2012, 64 (12) : 958 - 964
  • [25] Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Vita, Roberto
    Antonelli, Alessandro
    Benvenga, Salvatore
    PPAR RESEARCH, 2015, 2015
  • [26] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    CHEST, 2002, 122 (01) : 386 - 387
  • [27] Telmisartan Protects against Vascular Dysfunction with Peroxisome Proliferator-Activated Receptor-γ Activation in Hypertensive 5/6 Nephrectomized Rats
    Toba, Hiroe
    Wang, Jiahong
    Ohigashi, Makoto
    Kobara, Miyuki
    Nakata, Tetsuo
    PHARMACOLOGY, 2013, 92 (5-6) : 265 - 275
  • [28] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379
  • [29] Antifibrotic effect by activation of peroxisome proliferator-activated receptor-γ in corneal fibroblasts
    Pan, Hongwei
    Chen, Jiansu
    Xu, Jintang
    Chen, Miaojiao
    Ma, Rong
    MOLECULAR VISION, 2009, 15 (245): : 2279 - 2286
  • [30] Activation of peroxisome proliferator-activated receptor-γ pathway inhibits osteoclast differentiation
    Mbalaviele, G
    Abu-Amer, Y
    Meng, A
    Jaiswal, R
    Beck, S
    Pittenger, MF
    Thiede, MA
    Marshak, DR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) : 14388 - 14393